Quality Management in Manufacturing of Biopharmaceuticals

4.1 562 students

Quality Management in Manufacturing of Biopharmaceuticals

Three days on manufacturing biopharmaceuticals & quality aspects

4.1 562 students

for pharma & biotech

Languages:

3 days in total

€ 2280.00
excl. VAT

Registration ends in 103 days

Register now

This training's start date is guaranteed

What will you learn?

Understand how biopharmaceuticals are produced and what the differences are between small and large (biopharmaceutical) molecules, including the key process units for cell line development, upstream and downstream processing and how they impact product qu

Apply critical process parameters (CPP) and critical quality attributes (CQA) for biopharmaceuticals to achieve a robust process

Understand how relevant test methods are best applied and what their limitations are

Training description

The training


Biopharmaceuticals are the next generation of medicines. As they originate from live cells, there are several quality concerns and significant technical challenges during development, manufacturing and testing. This module provides participants with a solid understanding of the production of biopharmaceuticals, and critical aspects to understand during development.

Previously organized by PAO Farmacie, now by PCS Academy.

Target audience


Professionals in pharmaceutical and biotechnological industries, Professionals in institutions and Contract Research Organisations (CRO’s), Hospital pharmacists and Post-graduate students.

The course is aimed at (young) professionals in non-clinical and clinical development of new medicinal products, production, packaging, Quality Control, Quality Assurance or Regulatory Affairs who are dealing with complex quality systems. The target audience needs to gain an in-depth understanding of these systems to improve quality management in their own organization. The course is an international training program in English and requires, at minimum, a Bachelor’s Degree level (HBO level in the Netherlands).

What is it about?


This three-day training provides insight into the development of biopharmaceuticals and how this relates to quality aspects. We will consider the critical steps of developing cell lines, upstream and downstream processes, and commercial manufacturing up to protein analysis. Stability, comparability, contamination and immunogenicity will be discussed, as they require special attention compared to API's of non-biological origin.

Course structure


Expert knowledge and real-life case studies are combined to form an ideal learning experience. Professionals from industry and academia will share their wealth of experience and knowledge during the course.

The course is interactive. The program is offered as a combination of self-study, theory, and practical case studies.

Learning goals


After having followed this course, you will be able to:
  • Understand how biopharmaceuticals are produced and what the differences are between small and large (biopharmaceutical) molecules, including the key process units for cell line development, upstream and downstream processing and how they impact product quality.
  • Apply critical process parameters (CPP) and critical quality attributes (CQA) for biopharmaceuticals to achieve a robust process.
  • Understand how relevant test methods are best applied and what their limitations are.
  • Understand the up-to-date information on relevant ICH guidelines and have the knowledge where to find EMA and FDA guidance for biopharmaceuticals;
  • Apply the knowledge to achieve a compliant QP release of biopharmaceutical products according to the appropriate expectations.

Results


After having followed this course, you will have:
  • The knowledge to achieve a compliant QP release of biopharmaceutical products according to the appropriate expectations, including awareness of how process changes and small differences may impact quality and safety, including immunogenicity.
  • Fundamental tools to achieve a robust manufacturing process and insight into how CPP’s and CQA’s are established using different approaches.
  • Up-to-date information on relevant ICH guidelines and knowledge where to find EMA and FDA guidance for biopharmaceuticals.

Contents


  • Introduction to biotechnology
  • Upstream process development for biopharmaceutical products 
  • Cell line development and cell bank preparation
  • Purification survey of unit operations and process integration
  • Design of an industrial process for purification of biologicals
  • Development, tech transfer and commercial production of monoclonal antibodies by cell culture
  • Pathogen safety
  • Protein analytics of biopharmaceuticals
  • Critical attributes and comparability studies
  • Quality challenges for Advanced Therapy Medicinal Products (ATMP)
  • Biosimilars: a new class of licensed biotech products
  • Immunogenicity and formulation of biopharmaceuticals

More Information


Go to Quality Management in Pharma and Biotech for more information about the modules.

Date                22-24 November 2022
Location         Hotel van der Valk, Breukelen
Preparation    0-2 hours depending on prior knowledge
Exam              Yes, optional (re-exam possible)

Discount when following all four modules: 20%
Master and PhD students receive a discount of 25%
Prices exclude exam fees

In the event of cancellation, we refer to the general terms and conditions of PCS (www.pcs-nl.com).

Course leader


Drs. A.C.A.J. (Aad) van de Leur – Byondis B.V.

Aad van de Leur is working at Byondis BV (formerly Synthon Biopharmaceuticals BV). In his present function of COO he is responsible for all Biopharmaceutical operational activities including process development activities from cell line to Drug Product development and related analytical development as well as manufacturing and supply of IMPs with a focus on monoclonal Antibodies and Antibody Drug Conjugates (ADCs).
Before starting at Byondis, he worked for over 23 years at different Biotechnology departments at Diosynth and Organon/Schering-Plough including Cell Culture and Purification Development, Manufacturing and Project Management.

Training contents

15 lectures 3 days in total
    • Introduction
      00:05
    • Learning goals
      00:10
    • Introduction to biotechnology: applications and elements of the biotechnological production process; quality and regulatory aspects
      01:05
    • Upstream process development for biopharmaceutical products
      01:20
    • Theory and case study
      01:15
    • Purification survey of unit operations and process integration
      02:30
    • Design of an industrial process for purification of biologicals
      01:15
    • Development, tech transfer and commercial production of monoclonal antibodies by cell culture – Part 1
      02:00
    • Development, tech transfer and commercial production of monoclonal antibodies by cell culture – Part 2
      04:30
    • Protein analytics of biopharmaceuticals: relevant assays and their principles
      01:30
    • Pathogen safety
      01:30

Subject to changes. The final program will be sent to the participants approximately 1 week before the start of the training. No rights can be derived from this program.

Training dates

Training Price From Register
Quality Management in Manufacturing of Biopharmaceuticals
€ 2280.00 22-11-2022 Register now

Languages

Quality Course modules

This module is part of a series called: "Quality Management in Pharma and Biotech". This series is designed to give participants an in-depth understanding of the QP’s role and responsibilities. See the other modules in this series below.

4.0 1977 € 7650.00
3.7 343 € 2280.00
4.1 455 € 2280.00
Quality Management in Manufacturing of Biopharmaceuticals thumbnail
€ 2280.00
excl. VAT

Registration ends in 103 days

Register now

This training's start date is guaranteed

This training includes:

15 lectures

Lunch buffet

Training certificate

Copy of all course materials

Training 5 people or more?

In-house training may be your best choice! We have more than 100 GxP training courses on demand.